Cargando…
Preliminary Analysis of a Phase II Trial of Stereotactic Body Radiation Therapy for Prostate Cancer With High-Risk Features After Radical Prostatectomy
PURPOSE: There are limited data regarding using stereotactic body radiation therapy (SBRT) in the postprostatectomy setting. Here, we present a preliminary analysis of a prospective phase II trial that aimed to evaluate the safety and efficacy of postprostatectomy SBRT for adjuvant or early salvage...
Autores principales: | Laughlin, Brady S., Voss, Molly M., Toesca, Diego A.S., Daniels, Thomas, Golafshar, Michael A., Keole, Sameer R., Wong, William W., Rwigema, Jean-Claude, Davis, Brian, Schild, Steven E., Stish, Brad J., Choo, Richard, Lester, Scott, DeWees, Todd A., Vargas, Carlos E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9943785/ https://www.ncbi.nlm.nih.gov/pubmed/36845611 http://dx.doi.org/10.1016/j.adro.2022.101143 |
Ejemplares similares
-
Initial Quality of Life and Toxicity Analysis of a Randomized Phase 3 Study of Moderately Hypofractionated Radiation Therapy With or Without Androgen Suppression for Intermediate-Risk Adenocarcinoma of the Prostate: PCG GU003
por: Laughlin, Brady S., et al.
Publicado: (2022) -
Dose-volume histogram parameters and patient-reported EPIC-Bowel domain in prostate cancer proton therapy
por: Bulman, Gabriella F., et al.
Publicado: (2021) -
Biologically Effective Dose and Rectal Bleeding in Definitive Proton Therapy for Prostate Cancer
por: Bhangoo, Ronik S., et al.
Publicado: (2021) -
Clinical Practice Evolvement for Post-Operative Prostate Cancer Radiotherapy—Part 1: Consistent Organs at Risk Management with Advanced Image Guidance
por: Laughlin, Brady S., et al.
Publicado: (2022) -
Patient-reported outcomes for patients with breast cancer undergoing radiotherapy: A single-center registry experience
por: Laughlin, Brady S., et al.
Publicado: (2022)